Biotech Mineralys Therapeutics Presents New Late-Breaking Data from Transform-HTN Open-Label Extension Trial of Lorundrostat in Hypertension at AHA Scientific Sessions 2026 November 9, 2026
Technology NVIDIA, Rebellions and SK Telecom Announce Collaboration to Advance Sovereign AI Infrastructure With NVIDIA NVLink Fusion November 9, 2026
Automotive WeRide to Report Third Quarter 2026 Financial Results on Friday, November 20, 2026 November 9, 2026
Biotech argenx to Acquire Unnatural Products, Inc., Adding Peptide Discovery Engine to Broaden Immunology Capabilities November 9, 2026
Biotech ACR 2026: Dapirolizumab Pegol Associated with Greater Treatment Response Rates Versus Placebo in SLE Using Novel Treatment Response Measure November 9, 2026
Biotech argenx Presents Phase 3 ALKIVIA Data at ACR Convergence 2026 Showing Rapid and Sustained Improvement with Efgartigimod in Autoimmune Myositis November 8, 2026
Technology Diginex Announces Extension of Long Stop Date for Proposed Acquisition of Resulticks and Convenes Extraordinary General Meeting November 8, 2026
Technology Parker Scheduled to Present at Robert W. Baird Global Industrial Conference on November 10 at 10:50 a.m. Central Time (11:50 a.m. Eastern Time) November 7, 2026
Technology Constellation Software Inc. Announces Results for the Third Quarter Ended September 30, 2026 and Declares Quarterly Dividend November 7, 2026